Anti-Therapeutic Action: paralysis

The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology

Researchers are rediscovering psychedelic compounds from traditional plants and fungi as potential treatments for mental health conditions and addiction. These substances work by interacting with brain chemistry, particularly serotonin systems, to reduce symptoms of depression, anxiety, and drug cravings. Recent clinical studies show promising results, especially for treating opioid addiction with single doses that can produce lasting improvements. However, more rigorous clinical trials are needed to fully understand how these compounds work and to establish safe, effective therapeutic protocols.

Read More »

“Plants of the Gods” and their hallucinogenic powers in neuropharmacology — A review of two books

This review examines two books about plants that have been used in religious and healing rituals across many cultures for their mind-altering properties. The author verifies that the hallucinogenic plants described in Carlos Castaneda’s popular books about a Yaqui sorcerer are accurately portrayed pharmacologically. The review explains how different sacred plants like peyote, certain mushrooms, and nightshade varieties affect the brain through various chemical pathways, while noting their dangers when misused.

Read More »

A high-quality genome assembly of angel-wing mushroom Pleurocybella porrigens that causes acute encephalopathy

Scientists created a detailed genetic blueprint of the angel-wing mushroom, which caused serious poisonings in Japan. They identified three toxic compounds in the mushroom and found a gene that likely produces one of the most dangerous toxins responsible for brain damage. This research helps explain how the mushroom makes its poison and could lead to better understanding of foodborne illness prevention.

Read More »
Scroll to Top